Prolastin c 1,000 MG/20 ML VLS
Ended Awarded
- Contract number
- SPE2DB25FKEKE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,019
Award facts
- Contract value 100% obligated
- $18,019.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,019.40 by the Defense Logistics Agency (DLA) for the supply of Prolastin C 1,000 mg/20 ml vials. The contract employs firm fixed-price pricing with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation, reflecting the company's competitive positioning within federal procurement markets. The award is executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical items.
Prolastin C is a therapeutic product used to treat alpha-1 antitrypsin deficiency, a genetic disorder affecting the lungs and liver. DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain is demonstrated through its robust portfolio of delivery orders to the DLA, which supports medical supply needs for military health facilities nationwide. The company's contract awards encompass an extensive range of prescription medications, biologics, and medical consumables, positioning it as a key distributor of pharmaceutical products and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FKEKE?
SPE2DB25FKEKE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FKEKE worth?
The government has obligated $18,019 on SPE2DB25FKEKE.
Is contract SPE2DB25FKEKE an order under another contract?
Yes. SPE2DB25FKEKE is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKE competed?
The extent of competition for SPE2DB25FKEKE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award